-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R4v9j3EgHOaCg0K4jabjpslY92BoFot61ABRrtPpeP8JMPCicVgF/2EfgkIQeR1B uJsgp30jDTAUsAjtcAdFdA== 0000891836-01-500127.txt : 20010625 0000891836-01-500127.hdr.sgml : 20010625 ACCESSION NUMBER: 0000891836-01-500127 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010619 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20010622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-02516 FILM NUMBER: 1665402 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 8-K 1 sc0065-01a.htm FORM 8-K: CURRENT REPORT FORM 8-K: Current Report

As filed with the Securities and Exchange Commission on June 22, 2001

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of report (Date of earliest event reported)             June 19, 2001            


PHARMACIA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)


Delaware
(State or Other Jurisdiction of Incorporation)


1- 2516 43-0420020


(Commission File Number)


(IRS Employer Identification No.)


100 Route 206 North, Peapack, New Jersey 07977


(Address of Principal Executive Offices)


(Zip Code)


(908) 901-8000
(Registrant’s Telephone Number, Including Area Code)


N/A
(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Item 5.  Other Events.

             On June 19, 2001, the Registrant announced the resignation of John E. Robson from the Company’s Board of Directors following his recent appointment as Chairman and President of the Export-Import Bank of the United States. The Company also announced that the size of the Board was reduced to fourteen members.

             A copy of the press release issued by the Registrant on June 19, 2001 is attached hereto as Exhibit 99 and is hereby incorporated by reference herein.


Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

(c) Exhibits.

The following exhibit is filed as part of this Current Report on Form 8-K:

  99 Press Release of June 19, 2001.

 

 

 

SIGNATURES

             Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  PHARMACIA CORPORATION


Dated: June 22, 2001 By: /s/ Don W. Schmitz
   
    Name:
Title:
Don W. Schmitz
Vice President, Associate General
Counsel and Corporate Secretary

 

 

 

INDEX TO EXHIBITS



Exhibit No.

Exhibit

99 Press Release of June 19, 2001.

 

 

EX-99 2 sc0065-01b.htm EXHIBIT 99: PRESS RELEASE OF JUNE 19, 2001 EXHIBIT 99: Press Release of June 19, 2001

Exhibit 99


[PHARMACIA LOGO]

FOR IMMEDIATE RELEASE

Pharmacia Board of Directors Reduces Size

PEAPACK, NJ (June 19, 2001) - Pharmacia Corp. (NYSE: PHA) today announced the resignation of John E. Robson from the Company’s Board of Directors following his recent appointment as Chairman and President of the Export-Import Bank of the United States. Mr. Robson’s departure reduces the Pharmacia Board of Directors to 14 members.

Mr. Robson was appointed to the Pharmacia Board of Directors in conjunction with the merger of Pharmacia & Upjohn and Monsanto Company in March 2000. He had previously served on the Monsanto Board of Directors and as Chief Executive Officer and President of Monsanto’s G.D. Searle pharmaceutical unit. Most recently, Mr. Robson served as a Senior Advisor with the investment banking firm, Robertson Stephens.

Pharmacia Corporation (NYSE:PHA) is a top-tier global pharmaceutical company with a leading agricultural subsidiary. Pharmacia’s innovative medicines and other products save lives and enhance health and wellness. Pharmacia’s 59,000 people work together with many diverse stakeholders to bring these benefits to people around the world, and to create new health solutions for the future.

Media Contact:
Paul Fitzhenry
Tel. (908) 901-8770

Analyst Contact:
Craig Tooman
Tel. (908) 901-8853

             

-----END PRIVACY-ENHANCED MESSAGE-----